Ribociclib-induced vitiligo in a case of metastatic carcinoma of the breast

Ribociclib-induced vitiligo in a case of metastatic carcinoma of the breast

Ribociclib, a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, is commonly used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2/neu negative (HER2/neu-) breast cancer. While effective in inhibiting cancer cell proliferation, ribociclib has been associated with vario...

Full description

Saved in:
Bibliographic Details
Main Authors: Abhira Deb, Manthan Dhingra, Srutee Barman, Thinakaran Raja, Abhra Ghosh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Journal of the Egyptian Women’s Dermatologic Society
Subjects:
breast cancer
cyclin-dependent kinase 4/6 inhibitors
ribociclib
vitiligo
Online Access:https://journals.lww.com/10.4103/jewd.jewd_64_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.lww.com/10.4103/jewd.jewd_64_24

Similar Items